A 32-year-old woman with newly diagnosed sputum-positive pulmonary TB is started on RNTCP Category 1 regimen (2HRZE/4HR). After 2 months of treatment, her sputum smear microscopy remains positive. What is the most appropriate next step in management?

Explanation

## Management of Persistent Sputum Positivity at 2 Months **Key Point:** Persistent sputum positivity at 2 months of Category 1 therapy is a red flag for either treatment failure or drug-resistant TB (MDR-TB). The appropriate response is NOT to assume failure immediately, but to investigate for drug resistance while continuing standard therapy. ### RNTCP Protocol for Sputum Conversion Monitoring According to RNTCP guidelines, sputum smear examination is performed at: - 2 months (end of intensive phase) - 5 months (end of continuation phase) - 6 months (end of treatment) **High-Yield:** If sputum remains positive at 2 months, the patient is classified as a "slow responder" or suspected treatment failure. The next step is: 1. **Send sputum for DST and culture** to rule out MDR-TB or other drug-resistant strains 2. **Continue the current regimen** while awaiting results (do not stop treatment) 3. **Repeat sputum smear microscopy** at 3 months 4. **If still positive at 5 months** → declare treatment failure and switch to Category 2 regimen ### Decision Algorithm ```mermaid flowchart TD A[Sputum positive at 2 months]:::outcome --> B{Send DST/Culture?}:::decision B -->|Yes, continue RNTCP Cat 1| C[Await DST results]:::action B -->|No, declare failure immediately| D[Switch to Cat 2]:::urgent C --> E{DST results: Drug-resistant?}:::decision E -->|MDR-TB detected| F[Switch to MDR-TB regimen]:::action E -->|Drug-susceptible| G[Continue Cat 1, assess adherence]:::action G --> H[Repeat sputum at 5 months]:::action H -->|Still positive| I[Declare treatment failure]:::urgent H -->|Converted| J[Continue to completion]:::action ``` **Clinical Pearl:** Persistent positivity at 2 months may also indicate poor adherence, malabsorption, or inadequate dosing—all of which must be assessed before assuming drug resistance. **Warning:** Do NOT immediately switch to Category 2 regimen based on 2-month positivity alone; this is reserved for confirmed treatment failure (persistent positivity at 5 months or later). [cite:Park 26e Ch 9]